Physician profile
Jesse Lou
NPI 1134788953
$10,854.82
in general payments reported to CMS, 2019-2025
23 companies · $8,211 in 2025
The $8,211 reported for 2025 was more than what 98% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $153 · 2023: $1,557 · 2024: $934 · 2025: $8,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,014 · Travel and Lodging: $4,688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,013.55 |
| Travel and Lodging | $4,688.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,126.08 | 2023-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Vanta Adaptivestim |
| Boston Scientific Corporation | $2,938.55 | 2023-2025 | General - Therapies, Wavewriter Alpha Prime 16 |
| Globus Medical, INC. | $616.50 | 2024-2025 | Senza, Excelsius Gps, Archon |
| Stryker Corporation | $311.76 | 2024-2025 | Mild Device Kit, Optablate |
| Biotronik Nro, INC. | $223.62 | 2025 | Prospera |
| Nevro Corp. | $207.30 | 2024 | Senza |
| Curonix LLC | $193.32 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbvie INC. | $188.88 | 2024-2025 | |
| Si-Bone, INC. | $181.26 | 2022-2025 | |
| Ptc Therapeutics, INC. | $145.13 | 2023 | |
| Saluda Medical Americas, INC. | $137.24 | 2024-2025 | Evoke |
| Vertos Medical, INC. | $119.62 | 2023 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $96.32 | 2024-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $60.79 | 2025 | |
| Collegium Pharmaceutical, INC. | $60.26 | 2025 | Xtampza, Belbuca |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $58.86 | 2024-2025 | Qutenza |
| International Rehabilitative Sciences, INC | $43.14 | 2025 | Rs-4i Plus With Intersperse |
| Pfizer INC. | $40.43 | 2024 | |
| Abbott Laboratories | $36.96 | 2024-2025 | Eterna |
| Painteq LLC | $28.91 | 2024 | Painteq |
| Electronic Waveform Lab, INC. | $15.89 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $15.52 | 2025 | Austedo Xr |
| Zavation Medical Products, LLC | $8.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Lou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.